Send me a link:

*Text messaging rates may apply.

 Dow Down 0.05% Nasdaq Up 0.36%

Alkermes plc (ALKS)

-NasdaqGS
48.26 Up 0.46(0.96%) 1:37PM EDT - Nasdaq Real Time Price
Prev Close:47.80
Open:47.77
Bid:48.34 x 400
Ask:48.39 x 100
1y Target Est:50.92
Beta:1.5
Earnings Date:Jul 21 - Jul 25 (Est.)
Day's Range:47.28 - 48.45
52wk Range:28.86 - 54.25
Volume:231,662
Avg Vol (3m):893,592
Market Cap:6.97B
P/E (ttm):N/A
EPS (ttm):-0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALKS

Comparison

Symbol% ChgMkt Cap
ALKSUp 0.96%6.97B
ABTDown 0.17%61.83B
LLYUp 0.26%67.25B
GSKDown 1.05%129.57B

Key Statistics

Forward P/E (1 yr):70.09
P/S (ttm):12.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.49
Quarterly EPS Est (Jun-14) :0.14
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):7.47

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback